BETonMACE baseline data
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 12:11PM
|
Re: Resverlogix H2 2018 events
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 11:49AM
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 11:43AM
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 04, 2018 10:22AM
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 04, 2018 07:57AM
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 03, 2018 11:21PM
|
Re: Resverlogix H2 2018 events
|
5
|
Resverlogix Corp.
|
Nov 03, 2018 05:14PM
|
Re: MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 03, 2018 04:49PM
|
Re: 3 point MACE vs 5 point MACE
|
5
|
Resverlogix Corp.
|
Nov 02, 2018 11:48PM
|
Re: 3 point MACE vs 5 point MACE
|
4
|
Resverlogix Corp.
|
Nov 02, 2018 10:29PM
|
Re: 3 point MACE vs 5 point MACE
|
7
|
Resverlogix Corp.
|
Nov 02, 2018 05:50PM
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 02:54PM
|
Re: 3 point MACE vs 5 point MACE
|
3
|
Resverlogix Corp.
|
Nov 02, 2018 01:32PM
|
Re: 3 point MACE vs 5 point MACE
|
4
|
Resverlogix Corp.
|
Nov 02, 2018 01:23PM
|
Re: 3 point MACE vs 5 point MACE
|
5
|
Resverlogix Corp.
|
Nov 02, 2018 01:17PM
|
Re: 3 point MACE vs 5 point MACE
|
6
|
Resverlogix Corp.
|
Nov 02, 2018 10:41AM
|
Re: RVX buyout projection at $30 US minimum
|
4
|
Resverlogix Corp.
|
Nov 01, 2018 05:33PM
|
Re: Roth research report
|
2
|
Resverlogix Corp.
|
Nov 01, 2018 04:17PM
|
Re: The scariest thing for a clinical trial......
|
7
|
Resverlogix Corp.
|
Nov 01, 2018 10:58AM
|
Re: Roth research report
|
3
|
Resverlogix Corp.
|
Nov 01, 2018 09:47AM
|